These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21204525)

  • 1. NMR spectroscopy and molecular dynamics simulation of r(CCGCUGCGG)₂ reveal a dynamic UU internal loop found in myotonic dystrophy type 1.
    Parkesh R; Fountain M; Disney MD
    Biochemistry; 2011 Feb; 50(5):599-601. PubMed ID: 21204525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 RNA crystal structures reveal heterogeneous 1 × 1 nucleotide UU internal loop conformations.
    Kumar A; Park H; Fang P; Parkesh R; Guo M; Nettles KW; Disney MD
    Biochemistry; 2011 Nov; 50(45):9928-35. PubMed ID: 21988728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and Dynamics of RNA Repeat Expansions That Cause Huntington's Disease and Myotonic Dystrophy Type 1.
    Chen JL; VanEtten DM; Fountain MA; Yildirim I; Disney MD
    Biochemistry; 2017 Jul; 56(27):3463-3474. PubMed ID: 28617590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structures of small molecules bound to a model of a CUG RNA repeat expansion.
    Chen JL; Taghavi A; Frank AJ; Fountain MA; Choudhary S; Roy S; Childs-Disney JL; Disney MD
    Bioorg Med Chem Lett; 2024 Oct; 111():129888. PubMed ID: 39002937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.
    Childs-Disney JL; Hoskins J; Rzuczek SG; Thornton CA; Disney MD
    ACS Chem Biol; 2012 May; 7(5):856-62. PubMed ID: 22332923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing the GAAA tetraloop/receptor to facilitate crystal packing and determination of the structure of a CUG RNA helix.
    Coonrod LA; Lohman JR; Berglund JA
    Biochemistry; 2012 Oct; 51(42):8330-7. PubMed ID: 23025897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule-mediated cleavage of RNA in living cells.
    Guan L; Disney MD
    Angew Chem Int Ed Engl; 2013 Jan; 52(5):1462-5. PubMed ID: 23280953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR structures of small molecules bound to a model of an RNA CUG repeat expansion.
    Chen JL; Taghavi A; Frank AJ; Fountain MA; Choudhary S; Roy S; Childs-Disney JL; Disney MD
    bioRxiv; 2024 Jun; ():. PubMed ID: 38948793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural basis of myotonic dystrophy from the crystal structure of CUG repeats.
    Mooers BH; Logue JS; Berglund JA
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16626-31. PubMed ID: 16269545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity.
    Childs-Disney JL; Yildirim I; Park H; Lohman JR; Guan L; Tran T; Sarkar P; Schatz GC; Disney MD
    ACS Chem Biol; 2014 Feb; 9(2):538-550. PubMed ID: 24341895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins.
    Napierała M; Krzyzosiak WJ
    J Biol Chem; 1997 Dec; 272(49):31079-85. PubMed ID: 9388259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is myotonic dystrophy a single-gene disorder?
    Johnson KJ; Boucher Ca; King SK; Winchester CL; Bailey ME; Hamilton GM; Carey N
    Biochem Soc Trans; 1996 May; 24(2):510-3. PubMed ID: 8736794
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.
    Parkesh R; Childs-Disney JL; Nakamori M; Kumar A; Wang E; Wang T; Hoskins J; Tran T; Housman D; Thornton CA; Disney MD
    J Am Chem Soc; 2012 Mar; 134(10):4731-42. PubMed ID: 22300544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.
    Magaña JJ; Cortés-Reynosa P; Escobar-Cedillo R; Gómez R; Leyva-García N; Cisneros B
    Mol Biol Rep; 2011 Feb; 38(2):1341-6. PubMed ID: 20635151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy--a multigene disorder.
    Larkin K; Fardaei M
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):389-95. PubMed ID: 11719277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.
    Junghans RP; Ebralidze A; Tiwari B
    Neurogenetics; 2001 Mar; 3(2):59-67. PubMed ID: 11354827
    [No Abstract]   [Full Text] [Related]  

  • 17. Triplet-primed PCR is more sensitive than southern blotting-long PCR for the diagnosis of myotonic dystrophy type1.
    Addis M; Serrenti M; Meloni C; Cau M; Melis MA
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1428-31. PubMed ID: 23030650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
    Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology. Neutralizing toxic RNA.
    Cooper TA
    Science; 2009 Jul; 325(5938):272-3. PubMed ID: 19608901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.